RETINAFLUX THERAPEUTICS
LIVE

Serial Number

50098134

Owner

Retinaflux Therapeutics Corp.

Attorney

Nasser Khateeb

Filing Date

Sep 9, 2026

Add to watchlist:

No watchlists yet
View on USPTO

RETINAFLUX THERAPEUTICS Trademark

Serial Number: 50098134

RETINAFLUX THERAPEUTICS is a trademark filed by Retinaflux Therapeutics Corp. on September 9, 2026. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

Retinaflux Therapeutics Corp.

1806 Wyoming Ave NW
Washington, DC 20009

Entity Type: 03

Trademark Details

Filing Date

September 9, 2026

Registration Date

Not Registered

Goods & Services

Pharmaceutical preparations for the treatment of ophthalmic diseases; pharmaceutical preparations for the treatment of glaucoma; neuroprotective pharmaceutical preparations; drug delivery formulations for ocular use; therapeutic agents for preventing or slowing neurodegeneration; pharmaceutical preparations for the treatment of retinal and optic nerve disorders; biologics and small molecule therapeutics for neurological and ophthalmic indications.

Medical and clinical services relating to the diagnosis, prevention, and treatment of ophthalmic and neurodegenerative diseases; conducting clinical trials for pharmaceutical preparations; medical information services in the fields of ophthalmology, glaucoma, and neuroprotection.

Biotechnology research and development services; pharmaceutical research and development; research and development of neuroprotective therapeutics; laboratory research services in the field of ophthalmology, glaucoma, and neurodegeneration; drug discovery services; preclinical research services; development of drug delivery systems; scientific research for medical purposes in the field of ocular and neurological diseases.

Filing History

APPLICATION FILING RECEIPT MAILED
Sep 9, 2026 MAFR
NEW APPLICATION ENTERED
Sep 9, 2026 NWAP